|  Help  |  About  |  Contact Us

Publication : UHRF1 Controls Thymocyte Fate Decisions through the Epigenetic Regulation of EGR1 Expression.

First Author  Zhang Y Year  2020
Journal  J Immunol Volume  204
Issue  12 Pages  3248-3261
PubMed ID  32358021 Mgi Jnum  J:294658
Mgi Id  MGI:6445338 Doi  10.4049/jimmunol.1901471
Citation  Zhang Y, et al. (2020) UHRF1 Controls Thymocyte Fate Decisions through the Epigenetic Regulation of EGR1 Expression. J Immunol 204(12):3248-3261
abstractText  Thymocyte differentiation is a highly complex process that is accompanied by epigenetic changes. Ubiquitin-like containing PHD ring finger 1 (UHRF1) is a critical epigenetic modifier involved in various cellular processes. In this study, we demonstrated that it is highly expressed in T cell precursors of the thymus. Further, its deficiency results in significantly reduced thymocyte cellularity and thymus size in mice. Through systematic analysis based on single-cell RNA sequencing, we found that UHRF1 deficiency thwarts alphabeta T cell lineage development, whereas biasing gammadelta T lineage differentiation dampens the progression of immature single-positive cells. UHRF1 deficiency promotes the IL-17 secreting and RORgammat expression in gammadelta T cell, indicating a Tgammadelta17 phenotype. Further, the analysis of gene-regulatory networks demonstrated that UHRF1 controls the expression of early growth response 1 (EGR1). UHRF1 interacts with DNA methyltransferase 1 (DNMT1) at the CpG promoter region of Egr1 loci and affects the nearby chromatin modifications of H3K9me3 and H3K4me3. Taken together, our results demonstrate that UHRF1 is a key factor that mediates the epigenetic regulation of EGR1 and, consequently, thymocyte fate decisions.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

7 Bio Entities

Trail: Publication

0 Expression